ADMA BIOLOGICS, INC. Research and Development Expense
ADMA BIOLOGICS, INC. (ADMA) reported Research and Development Expense of $6.01 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-05
- ADMA BIOLOGICS, INC. research and development expense for the quarter ending 2026-06-30 was $6.01M, a 483.32% increase year-over-year.
- ADMA BIOLOGICS, INC. research and development expense for the quarter ending 2026-03-31 was $2.60M, a 214.41% increase year-over-year.
- ADMA BIOLOGICS, INC. research and development expense for the quarter ending 2025-12-31 was $1.38M, a 251.92% increase year-over-year.
- ADMA BIOLOGICS, INC. research and development expense for the quarter ending 2025-09-30 was $1.53M, a 270.87% increase year-over-year.
- ADMA BIOLOGICS, INC. research and development expense for fiscal 2025 was $4.76M, a 162.66% increase from fiscal 2024.
- ADMA BIOLOGICS, INC. research and development expense for fiscal 2024 was $1.81M, a 45.06% decline from fiscal 2023.
- ADMA BIOLOGICS, INC. research and development expense for fiscal 2023 was $3.30M, a 8.69% decline from fiscal 2022.
- ADMA BIOLOGICS, INC. research and development expense for fiscal 2022 was $3.61M, a 0.88% decline from fiscal 2021.
| Period end | Research and Development Expense | Research and Development Expense as first filed | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.01M 10-Q · filed 2026-08-05 | $8.61M 10-Q · filed 2026-08-05 | $9.99M derived: sum of 3 quarters · filed 2026-08-05 | $11.52M derived: sum of 4 quarters · filed 2026-08-05 | ||||||
| 2026-03-31 | $2.60M 10-Q · filed 2026-05-06 | $3.97M derived: sum of 2 quarters · filed 2026-05-06 | $5.50M derived: sum of 3 quarters · filed 2026-05-06 | $6.53M derived: sum of 4 quarters · filed 2026-08-05 | ||||||
| 2025-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.90M derived: sum of 2 quarters · filed 2026-02-25 | $3.94M derived: sum of 3 quarters · filed 2026-08-05 | $4.76M 10-K · filed 2026-02-25 | ||||||
| 2025-09-30 | $1.53M 10-Q · filed 2025-11-05 | $2.56M derived: sum of 2 quarters · filed 2026-08-05 | $3.39M 10-Q · filed 2025-11-05 | $3.78M derived: sum of 4 quarters · filed 2026-08-05 | ||||||
| 2025-06-30 | $1.03M 10-Q · filed 2026-08-05 | $1.86M 10-Q · filed 2026-08-05 | $2.25M derived: sum of 3 quarters · filed 2026-08-05 | $2.66M derived: sum of 4 quarters · filed 2026-08-05 | ||||||
| 2025-03-31 | $826.00K 10-Q · filed 2026-05-06 | $1.22M derived: sum of 2 quarters · filed 2026-05-06 | $1.63M derived: sum of 3 quarters · filed 2026-05-06 | $2.19M derived: sum of 4 quarters · filed 2026-05-06 | ||||||
| 2024-12-31 | $391.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $803.00K derived: sum of 2 quarters · filed 2026-02-25 | $1.36M derived: sum of 3 quarters · filed 2026-02-25 | $1.81M 10-K · filed 2026-02-25 | ||||||
| 2024-09-30 | $412.00K 10-Q · filed 2025-11-05 | $972.00K derived: sum of 2 quarters · filed 2025-11-05 | $1.42M 10-Q · filed 2025-11-05 | $1.87M derived: sum of 4 quarters · filed 2026-02-25 | ||||||
| 2024-06-30 | $560.00K 10-Q · filed 2025-08-06 | $1.01M 10-Q · filed 2025-08-06 | $1.46M derived: sum of 3 quarters · filed 2026-02-25 | $2.05M derived: sum of 4 quarters · filed 2026-02-25 | ||||||
| 2024-03-31 | $450.00K 10-Q · filed 2025-05-07 | $896.00K derived: sum of 2 quarters · filed 2026-02-25 | $1.49M derived: sum of 3 quarters · filed 2026-02-25 | $2.90M derived: sum of 4 quarters · filed 2026-02-25 | ||||||
| 2023-12-31 | $446.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.04M derived: sum of 2 quarters · filed 2026-02-25 | $2.44M derived: sum of 3 quarters · filed 2026-02-25 | $3.30M 10-K · filed 2026-02-25 | ||||||
| 2023-09-30 | $596.00K 10-Q · filed 2024-11-07 | $595.90K 10-Q · filed 2023-11-08 | $2.00M derived: sum of 2 quarters · filed 2024-11-07 | $2.85M 10-Q · filed 2024-11-07 | $2.85M 10-Q · filed 2023-11-08 | $3.93M derived: sum of 4 quarters · filed 2025-03-18 | ||||
| 2023-06-30 | $1.40M 10-Q · filed 2024-08-08 | $1.40M 10-Q · filed 2023-08-09 | $2.26M 10-Q · filed 2024-08-08 | $2.26M 10-Q · filed 2023-08-09 | $3.33M derived: sum of 3 quarters · filed 2025-03-18 | $4.37M derived: sum of 4 quarters · filed 2025-03-18 | ||||
| 2023-03-31 | $855.00K 10-Q · filed 2024-05-09 | $855.35K 10-Q · filed 2023-05-10 | $1.93M derived: sum of 2 quarters · filed 2025-03-18 | $2.97M derived: sum of 3 quarters · filed 2025-03-18 | $3.84M derived: sum of 4 quarters · filed 2025-03-18 | |||||
| 2022-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $2.12M derived: sum of 2 quarters · filed 2025-03-18 | $2.99M derived: sum of 3 quarters · filed 2025-03-18 | $3.61M 10-K · filed 2025-03-18 | $3.61M 10-K · filed 2023-03-23 | |||||
| 2022-09-30 | $1.04M 10-Q · filed 2023-11-08 | $1.92M derived: sum of 2 quarters · filed 2023-11-08 | $2.54M 10-Q · filed 2023-11-08 | $3.27M derived: sum of 4 quarters · filed 2024-02-28 | ||||||
| 2022-06-30 | $873.39K 10-Q · filed 2023-08-09 | $1.50M 10-Q · filed 2023-08-09 | $2.23M derived: sum of 3 quarters · filed 2024-02-28 | $3.00M derived: sum of 4 quarters · filed 2024-02-28 | ||||||
| 2022-03-31 | $624.11K 10-Q · filed 2023-05-10 | $1.35M derived: sum of 2 quarters · filed 2024-02-28 | $2.12M derived: sum of 3 quarters · filed 2024-02-28 | $3.28M derived: sum of 4 quarters · filed 2024-02-28 | ||||||
| 2021-12-31 | $728.93K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.50M derived: sum of 2 quarters · filed 2024-02-28 | $2.66M derived: sum of 3 quarters · filed 2024-02-28 | $3.65M 10-K · filed 2024-02-28 | $3.65M 10-K · filed 2022-03-24 | |||||
| 2021-09-30 | $770.56K 10-Q · filed 2022-11-09 | $1.93M derived: sum of 2 quarters · filed 2022-11-09 | $2.92M 10-Q · filed 2022-11-09 | $3.93M derived: sum of 4 quarters · filed 2022-11-09 | ||||||
| 2021-06-30 | $1.16M 10-Q · filed 2022-08-10 | $2.15M 10-Q · filed 2022-08-10 | $3.16M derived: sum of 3 quarters · filed 2022-08-10 | $4.87M derived: sum of 4 quarters · filed 2022-08-10 | ||||||
| 2021-03-31 | $987.65K 10-Q · filed 2022-05-11 | $2.00M derived: sum of 2 quarters · filed 2022-05-11 | $3.71M derived: sum of 3 quarters · filed 2022-05-11 | $5.37M derived: sum of 4 quarters · filed 2022-05-11 | ||||||
| 2020-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $2.72M derived: sum of 2 quarters · filed 2022-03-24 | $4.38M derived: sum of 3 quarters · filed 2022-03-24 | $5.91M 10-K · filed 2022-03-24 | ||||||
| 2020-09-30 | $1.71M 10-Q · filed 2021-11-10 | $3.36M derived: sum of 2 quarters · filed 2021-11-10 | $4.89M 10-Q · filed 2021-11-10 | $5.36M derived: sum of 4 quarters · filed 2021-11-10 | ||||||
| 2020-06-30 | $1.66M 10-Q · filed 2021-08-11 | $3.19M 10-Q · filed 2021-08-11 | $3.65M derived: sum of 3 quarters · filed 2021-08-11 | $4.14M derived: sum of 4 quarters · filed 2021-08-11 | ||||||
| 2020-03-31 | $1.53M 10-Q · filed 2021-05-12 | $1.99M derived: sum of 2 quarters · filed 2021-05-12 | $2.48M derived: sum of 3 quarters · filed 2021-05-12 | $3.00M derived: sum of 4 quarters · filed 2021-05-12 | ||||||
| 2019-12-31 | $464.82K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $956.23K derived: sum of 2 quarters · filed 2021-03-25 | $1.47M derived: sum of 3 quarters · filed 2021-03-25 | $2.34M 10-K · filed 2021-03-25 | ||||||
| 2019-09-30 | $491.40K 10-Q · filed 2020-11-05 | $1.01M derived: sum of 2 quarters · filed 2020-11-05 | $1.88M 10-Q · filed 2020-11-05 | $2.80M derived: sum of 4 quarters · filed 2020-11-05 | ||||||
| 2019-06-30 | $516.99K 10-Q · filed 2020-08-05 | $1.39M 10-Q · filed 2020-08-05 | $2.30M derived: sum of 3 quarters · filed 2020-08-05 | $3.31M derived: sum of 4 quarters · filed 2020-08-05 | ||||||
| 2019-04-01 | $300.00K 10-Q · filed 2025-05-07 | $2.00M 10-K · filed 2022-03-24 | ||||||||
| 2019-03-31 | $870.63K 10-Q · filed 2020-05-06 | $1.79M derived: sum of 2 quarters · filed 2020-05-06 | $2.79M derived: sum of 3 quarters · filed 2020-05-06 | $3.83M derived: sum of 4 quarters · filed 2020-05-06 | ||||||
| 2018-12-31 | $917.30K 10-K · filed 2019-03-13 | $1.92M derived: sum of 2 quarters · filed 2019-11-06 | $2.96M derived: sum of 3 quarters · filed 2019-11-06 | $3.93M 10-K · filed 2020-03-13 | ||||||
| 2018-09-30 | $1.00M 10-Q · filed 2019-11-06 | $1.32M 10-Q · filed 2018-11-09 | $2.04M derived: sum of 2 quarters · filed 2019-11-06 | $3.01M 10-Q · filed 2019-11-06 | $4.07M 10-Q · filed 2018-11-09 | $4.21M derived: sum of 4 quarters · filed 2019-11-06 | ||||
| 2018-06-30 | $1.04M 10-Q · filed 2019-08-08 | $1.47M 10-Q · filed 2018-08-10 | $2.01M 10-Q · filed 2019-08-08 | $2.75M 10-Q · filed 2018-08-10 | $3.21M derived: sum of 3 quarters · filed 2019-08-08 | $5.02M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $965.57K 10-Q · filed 2019-05-08 | $1.28M 10-Q · filed 2018-05-14 | $2.17M derived: sum of 2 quarters · filed 2019-05-08 | $3.98M derived: sum of 3 quarters · filed 2019-05-08 | $5.34M derived: sum of 4 quarters · filed 2019-05-08 | |||||
| 2017-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $3.02M derived: sum of 2 quarters · filed 2019-03-13 | $4.38M derived: sum of 3 quarters · filed 2019-03-13 | $5.57M 10-K · filed 2019-03-13 | $6.23M 10-K · filed 2018-03-29 | |||||
| 2017-09-30 | $1.81M 10-Q · filed 2018-11-09 | $3.17M derived: sum of 2 quarters · filed 2018-11-09 | $4.37M 10-Q · filed 2018-11-09 | $4.95M derived: sum of 4 quarters · filed 2018-11-09 | ||||||
| 2017-06-30 | $1.36M 10-Q · filed 2018-08-10 | $2.55M 10-Q · filed 2018-08-10 | $3.13M derived: sum of 3 quarters · filed 2018-08-10 | $4.81M derived: sum of 4 quarters · filed 2018-08-10 | ||||||
| 2017-03-31 | $1.19M 10-Q · filed 2018-05-14 | $1.78M derived: sum of 2 quarters · filed 2018-05-14 | $3.45M derived: sum of 3 quarters · filed 2018-05-14 | $6.85M derived: sum of 4 quarters · filed 2018-05-14 | ||||||
| 2016-12-31 | $583.37K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $2.26M derived: sum of 2 quarters · filed 2018-03-29 | $5.66M derived: sum of 3 quarters · filed 2018-03-29 | $7.69M 10-K · filed 2018-03-29 | ||||||
| 2016-09-30 | $1.68M 10-Q · filed 2017-11-03 | $5.08M derived: sum of 2 quarters · filed 2017-11-03 | $7.10M 10-Q · filed 2017-11-03 | $9.10M derived: sum of 4 quarters · filed 2017-11-03 | ||||||
| 2016-06-30 | $3.40M 10-Q · filed 2017-08-11 | $5.43M 10-Q · filed 2017-08-11 | $7.42M derived: sum of 3 quarters · filed 2017-08-11 | $9.54M derived: sum of 4 quarters · filed 2017-08-11 | ||||||
| 2016-03-31 | $2.03M 10-Q · filed 2017-05-12 | $4.02M derived: sum of 2 quarters · filed 2017-05-12 | $6.14M derived: sum of 3 quarters · filed 2017-05-12 | $7.64M derived: sum of 4 quarters · filed 2017-05-12 | ||||||
| 2015-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $4.11M derived: sum of 2 quarters · filed 2017-02-24 | $5.61M derived: sum of 3 quarters · filed 2017-02-24 | $7.02M 10-K · filed 2017-02-24 | ||||||
| 2015-09-30 | $2.11M 10-Q · filed 2016-11-10 | $3.62M derived: sum of 2 quarters · filed 2016-11-10 | $5.02M 10-Q · filed 2016-11-10 | $6.94M derived: sum of 4 quarters · filed 2016-11-10 | ||||||
| 2015-06-30 | $1.51M 10-Q · filed 2016-08-12 | $2.91M 10-Q · filed 2016-08-12 | $4.83M derived: sum of 3 quarters · filed 2016-08-12 | $6.31M derived: sum of 4 quarters · filed 2016-08-12 | ||||||
| 2015-03-31 | $1.40M 10-Q · filed 2016-05-13 | $3.32M derived: sum of 2 quarters · filed 2016-05-13 | $4.80M derived: sum of 3 quarters · filed 2016-05-13 | $6.59M derived: sum of 4 quarters · filed 2016-05-13 | ||||||
| 2014-12-31 | $1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | $3.40M derived: sum of 2 quarters · filed 2016-03-23 | $5.19M derived: sum of 3 quarters · filed 2016-03-23 | $9.52M 10-K · filed 2016-03-23 | ||||||
| 2014-09-30 | $1.48M 10-Q · filed 2015-11-10 | $3.27M derived: sum of 2 quarters · filed 2015-11-10 | $7.60M 10-Q · filed 2015-11-10 | $10.55M derived: sum of 4 quarters · filed 2015-11-10 | ||||||
| 2014-06-30 | $1.78M 10-Q · filed 2015-08-11 | $6.11M 10-Q · filed 2015-08-11 | $9.07M derived: sum of 3 quarters · filed 2015-08-11 | $10.48M derived: sum of 4 quarters · filed 2015-08-11 | ||||||
| 2014-03-31 | $4.33M 10-Q · filed 2015-05-12 | $7.29M derived: sum of 2 quarters · filed 2015-05-12 | $8.70M derived: sum of 3 quarters · filed 2015-05-12 | $12.17M derived: sum of 4 quarters · filed 2015-05-12 | ||||||
| 2013-12-31 | $2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $4.37M derived: sum of 2 quarters · filed 2015-03-09 | $7.84M derived: sum of 3 quarters · filed 2015-03-09 | $9.30M 10-K · filed 2015-03-09 | ||||||
| 2013-09-30 | $1.41M 10-Q · filed 2014-11-10 | $4.88M derived: sum of 2 quarters · filed 2014-11-10 | $6.35M 10-Q · filed 2014-11-10 | $7.61M derived: sum of 4 quarters · filed 2014-11-10 | ||||||
| 2013-06-30 | $3.47M 10-Q · filed 2014-08-11 | $4.94M 10-Q · filed 2014-08-11 | $6.21M derived: sum of 3 quarters · filed 2014-08-11 | $8.15M derived: sum of 4 quarters · filed 2014-08-11 | ||||||
| 2013-03-31 | $1.47M 10-Q · filed 2014-05-12 | $2.74M derived: sum of 2 quarters · filed 2014-05-12 | $4.68M derived: sum of 3 quarters · filed 2014-05-12 | $4.85M derived: sum of 4 quarters · filed 2014-05-12 | ||||||
| 2012-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $3.21M derived: sum of 2 quarters · filed 2014-03-28 | $3.39M derived: sum of 3 quarters · filed 2014-03-28 | $3.47M 10-K · filed 2014-03-28 | ||||||
| 2012-12-19 | $2.00M 10-K · filed 2023-03-23 | |||||||||
| 2012-09-30 | $1.94M 10-Q · filed 2013-11-12 | $2.12M derived: sum of 2 quarters · filed 2013-11-12 | $2.20M 10-Q · filed 2013-11-12 | $2.40M derived: sum of 4 quarters · filed 2013-11-12 | ||||||
| 2012-06-30 | $178.67K 10-Q · filed 2013-08-12 | $260.49K 10-Q · filed 2013-08-12 | $464.06K derived: sum of 3 quarters · filed 2013-08-12 | $520.67K derived: sum of 4 quarters · filed 2013-08-12 | ||||||
| 2012-03-31 | $81.82K 10-Q · filed 2013-05-14 | $285.39K derived: sum of 2 quarters · filed 2013-05-14 | $342.00K derived: sum of 3 quarters · filed 2013-05-14 | $481.68K derived: sum of 4 quarters · filed 2013-05-14 | ||||||
| 2011-12-31 | $203.57K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-06 | $260.18K derived: sum of 2 quarters · filed 2013-03-06 | $399.86K derived: sum of 3 quarters · filed 2013-03-06 | $646.76K 10-K · filed 2013-03-06 | ||||||
| 2011-09-30 | $56.61K 10-Q · filed 2012-11-13 | $196.29K derived: sum of 2 quarters · filed 2012-11-13 | $443.19K 10-Q · filed 2012-11-13 | |||||||
| 2011-06-30 | $139.68K 10-Q · filed 2012-08-14 | $386.58K 10-Q · filed 2012-08-14 | ||||||||
| 2011-03-31 | $246.90K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |